Literature DB >> 28880453

Letter: the importance of dosing and baseline haemoglobin when establishing the relative efficacy of intravenous iron therapies-authors' reply.

A Aksan1,2, H Işık3, H H Radeke2,4, A Dignass2,5, J Stein2,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28880453     DOI： 10.1111/apt.14269

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN： 0269-2813            Impact factor:   8.171


× No keyword cloud information.
  3 in total

1.  Response: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark.

Authors:  Richard F Pollock; Gorden Muduma
Journal:  Adv Ther       Date:  2019-06-01       Impact factor: 3.845

2.  Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland.

Authors:  Aysegül Aksan; Alain Schoepfer; Pascal Juillerat; Stephan Vavricka; Miguel Bettencourt; Antonio Ramirez de Arellano; Simona Gavata; Neige Morin; William J Valentine; Barnaby Hunt
Journal:  Adv Ther       Date:  2020-11-20       Impact factor: 3.845

3.  Evaluation of the Cost-Effectiveness of Iron Formulations for the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease in the UK.

Authors:  Aysegül Aksan; Ian L P Beales; Garth Baxter; Antonio Ramirez de Arellano; Simona Gavata; William J Valentine; Barnaby Hunt
Journal:  Clinicoecon Outcomes Res       Date:  2021-06-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.